DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

被引：11
|
作者：
STECHER, VJ
CARLSON, JA
CONNOLLY, KM
BAILEY, DM
机构：
来源：
MEDICINAL RESEARCH REVIEWS | 1985年 / 5卷 / 03期
关键词：
D O I：
10.1002/med.2610050305
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：371 / 390
页数：20
相关论文
共 50 条
  • [41] Disease-Modifying Antirheumatic Drugs (DMARDs) and drug interactions in dentistry
    Munoz-Martinez, C.
    Segura-Puertas, M.
    Gomez-Moreno, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2834 - 2842
  • [42] Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis
    Lin, ATH
    Clements, PJ
    Furst, DE
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (02) : 409 - +
  • [43] Perioperative management of disease-modifying antirheumatic drugs and other immunomodulators
    Pinho, A. M.
    Duarte, C.
    Ferreira, R. J. O.
    ARP RHEUMATOLOGY, 2023, 2 (02): : 177 - 178
  • [44] Disease-Modifying Antirheumatic Drugs in PregnancyCurrent Status and Implications for the Future
    Fokaline Vroom
    Hermien E. K. de Walle
    Mart A. J. F. van de Laar
    Jacobus R. B. J. Brouwers
    Lolkje T. W. de Jong-van den Berg
    Drug Safety, 2006, 29 : 845 - 863
  • [45] The Relationship Between Autoimmune Disease and Disease-Modifying Antirheumatic Drugs on Wound Healing
    Kirloskar, Kunal M.
    Dekker, Paige K.
    Kiene, Julianne
    Zhou, Suzanne
    Bekeny, Jenna C.
    Rogers, Ashley
    Zolper, Elizabeth G.
    Fan, Kenneth L.
    Evans, Karen K.
    Benedict, Carol Deane
    Pasieka, Helena B.
    Attinger, Christopher E.
    ADVANCES IN WOUND CARE, 2022, 11 (12) : 650 - 656
  • [46] Previous Use of Conventional Disease-Modifying Antirheumatic Drugs and Response to Baricitinib
    Kavanaugh, Arthur
    van Vollenhoven, Ronald
    Muram, David
    Alam, Jahangir
    Arora, Vipin
    Correia, Ana-Luisa de Macedo Pinto
    de la Torre, Inmaculada
    O'Dell, James
    Faraawi, Rafat
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 891 - 891
  • [47] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS OPTIONS FOR MYOSITIS IN UK CLINICAL PRACTICE
    Prieto, Cristina Parraga
    Galloway, James
    Ming, Caroline
    Chinoy, Hector
    Gordon, Patrick
    RHEUMATOLOGY, 2015, 54 : 123 - 123
  • [48] A multidisciplinary approach for the assessment of drug interactions with disease-modifying antirheumatic drugs
    Van Roon, EN
    Wu, M
    Idzinga, F
    Van den Bernt, PMLA
    Jansen, TLTH
    Houtman, NM
    Van de Laar, MAFJ
    Wilffert, B
    Brouwers, JRBJ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 462 - 462
  • [49] Previous Use of Conventional Disease-Modifying Antirheumatic Drugs and Response to Baricitinib
    Kavanaugh, Arthur F.
    van Vollenhoven, Ronald F.
    Muram, David
    Alam, Jahangir
    Arora, Vipin
    Correia, Ana Luisa de Macedo Pinto
    de la Torre, Inmaculada
    O'Dell, James R.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs
    Sizova, Lyudmila
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (02) : 173 - 178
12345